LENZ Therapeutics, Inc. (LENZ)
6.71
-0.30
(-4.28%)
USD |
NASDAQ |
Jun 08, 16:00
6.72
+0.01
(+0.15%)
After-Hours: 20:00
LENZ Therapeutics Shareholders Equity (Quarterly) : 246.49M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 581.57M |
| NRX Pharmaceuticals, Inc. | -13.82M |
| ANI Pharmaceuticals, Inc. | 562.30M |
| Corcept Therapeutics, Inc. | 637.99M |
| Assertio Holdings, Inc. | 75.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 272.54M |
| Total Liabilities (Quarterly) | 26.04M |
| Debt to Equity Ratio | 0.0027 |
| Current Ratio | 10.40 |
| Net Debt Paydown Yield | 0.05% |